Hypercoagulability in Cirrhosis

Pathophysiology

Cirrhotic patients exhibit a paradoxical hypercoagulable state due to an imbalance between procoagulant and anticoagulant factors, with elevated factor VIII and von Willebrand factor coupled with decreased protein C being the primary drivers of hypercoagulability 1, 2
Decreased liver-derived anticoagulant factors, especially protein C, coupled with elevated endothelial-derived factor VIII creates a procoagulant imbalance 2
Elevated levels of von Willebrand factor (vWF) compensate for thrombocytopenia and platelet dysfunction, further promoting clot formation 1

Endotoxin absorption from intestines into systemic circulation leads to sustained inflammation that triggers platelet and coagulation activation 3
Portal hypertension creates low-flow states in the portal system, promoting stasis and activation of coagulation factors 3
Dilated collateral circulation and congestive splenomegaly provide a large endothelial surface that can become activated in the context of blood stasis and local inflammation 3

Decreased liver-derived anticoagulant proteins (protein C, protein S, antithrombin) with relatively preserved or increased procoagulant factors (especially factor VIII) 2, 4
Enhanced in vivo platelet activation despite thrombocytopenia 5

Increased risk of portal vein thrombosis (PVT) and venous thromboembolism (VTE) 4
Potential contribution to disease progression through intrahepatic microvascular thrombosis 4
Correlation between increased vWF production and worsening ascites, increased variceal hemorrhage, bacterial infections, and worse transplantation-free survival 4

Traditional coagulation tests (PT/INR, aPTT) fail to capture the hypercoagulable state as they only measure procoagulant factors but not anticoagulant deficiencies 2
Whole-blood viscoelastic tests may provide more comprehensive assessment of hemostasis but have not been fully validated in this population 2, 4

Do not rely on prolonged INR as evidence of bleeding risk; it systematically underestimates coagulation capacity in cirrhosis 2
The hemostatic balance in cirrhosis is unstable and can rapidly shift toward either bleeding or thrombosis depending on clinical circumstances 6
Patients with compensated and decompensated cirrhosis generally appear normo- to hypercoagulable, while those with acute-on-chronic liver failure may develop hypocoagulability 6
Prophylactic anticoagulation should not be withheld based solely on abnormal coagulation tests in hospitalized cirrhotic patients 4
Systemic infections and sepsis can further tip the balance toward hypercoagulability 6, 7
Renal failure can alter the hemostatic balance 2
Hepatocyte necrosis with release of tissue factor may trigger coagulation activation 3